|AHFS/Drugs.com||International Drug Names|
|Chemical and physical data|
|Molar mass||300.289 g/mol|
|3D model (Jmol)|
|(what is this?)|
Tazobactam is a pharmaceutical drug that inhibits the action of bacterial β-lactamases, especially those belonging to the SHV-1 and TEM groups. It is commonly used as its sodium salt, tazobactam sodium.
Tazobactam is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin/tazobactam, used in infections due Pseudomonas aeruginosa. Tazobactam broadens the spectrum of piperacillin by making it effective against organisms that express β-lactamase and would normally degrade piperacillin.
Tazobactam was patented in 1982 and came into medical use in 1992.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|